Dockets
Federal rulemakings, soonest-closing first — each gathers its documents and comments.
Agency ▾
Endangered and Threatened Wildlife and Plants; 90-Day Findings; Goose Lake Tui Chub
Endangered and Threatened Wildlife and Plants; 90-Day Findings; Goose Lake Lamprey
Benjamin Edelman and Mike Borsetti - Third-Party Complaint Against American Airlines
Esa Breadner - Exemption/Rulemaking
2025 Small Community Air Service Development Program
Requests that the FDA Invite the drug sponsor, Brainstorm Cell Therapeutics, to re-file its Biologics License Application (BLA) for debamestrocel (aka NurOwn), a first-in-class, autologous, mesenchymal stem cell therapy enhanced with neurotrophic factors. Approve debamestrocel for ALS, with a Phase 4 study mandating participation in a biorepository with a natural history and exposome database.
Endangered and Threatened Wildlife and Plants; 90-Day Findings for ten Species; Southwest spring firefly
Psychedelic Drugs: Considerations for Clinical Investigations; Draft Guidance for Industry; Availability
Request that the FDA amend the prescription status of triptan medications to allow their availability as over-the-counter (OTC) products for the acute treatment of migraine headaches with or without aura in adults who have a previous diagnosis of migrainie
Shay Hazkani - Third-Party Complaint Against American Airlines
Development of Non-Opioid Analgesics for Chronic Pain, Draft Guidance for Industry; Availability
SkyWest Airlines, Inc. - Notice of Intent to Terminate Scheduled Air Service at Imperial, California